Literature DB >> 2187802

Isolation and characterization of cell surface mutants of Candida albicans.

W L Whelan1, J M Delga, E Wadsworth, T J Walsh, K J Kwon-Chung, R Calderone, P N Lipke.   

Abstract

Mutant strains of Candida albicans were obtained by selecting for cells that escaped agglutination by a polyclonal antiserum raised against standard C. albicans serotype A isolate B311. Mutants were obtained from strains B311 and B792 and from four strains isolated from patients with acquired immunodeficiency syndrome. All 15 tested mutants retained characteristic sugar assimilation patterns. All but one of the mutants retained the ability to form germ tubes and chlamydospores. Two mutants from an acquired immunodeficiency syndrome-derived isolate were deficient in binding complement ligands iC3b and C3d, whereas another mutant was deficient in binding ligand iC3b but not C3d. The hyphae of these three mutants lacked antigens when examined by Western immunoblotting with monoclonal antibody Ca-A, which detects several glycoproteins, including C3d-binding proteins. One of the complement-binding-deficient mutants was tested for its ability to colonize the gastrointestinal tract of rabbits but did not differ from the wild-type parent in site or degree of colonization. The proton magnetic resonance spectra of bulk mannan carbohydrate extracted from tested mutants showed the loss of a signal characteristic of the mannosyl alpha-PO4 linkage; each mutant also had a distinct pattern of other changes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187802      PMCID: PMC258673          DOI: 10.1128/iai.58.6.1552-1557.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Candida albicans C3d receptor, isolated by using a monoclonal antibody.

Authors:  L Linehan; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

Review 2.  Candida albicans: biology, genetics, and pathogenicity.

Authors:  M G Shepherd; R T Poulter; P A Sullivan
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

3.  The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro.

Authors:  L P Samaranayake; T W MacFarlane
Journal:  Arch Oral Biol       Date:  1981       Impact factor: 2.633

4.  Relationship between cell surface composition, adherence, and virulence of Candida albicans.

Authors:  J McCourtie; L J Douglas
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

6.  Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants.

Authors:  R A Calderone; R L Cihlar; D D Lee; K Hoberg; W M Scheld
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

Review 7.  Antigenic variability of Candida albicans.

Authors:  D Poulain; V Hopwood; A Vernes
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

8.  Method for fingerprinting yeast cell wall mannans.

Authors:  J Kocourek; C E Ballou
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

9.  Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

10.  Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro.

Authors:  R L Sandin; A L Rogers; R J Patterson; E S Beneke
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more
  18 in total

Review 1.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

2.  New assay for measuring cell surface hydrophobicities of Candida dubliniensis and Candida albicans.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; T F Meiller
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Authors:  K C Hazen; J G Wu; J Masuoka
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Comparison between methods for serotyping of Candida albicans produces discrepancies in results.

Authors:  D L Brawner
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

5.  Inhibition of hydrophobic protein-mediated Candida albicans attachment to endothelial cells during physiologic shear flow.

Authors:  P M Glee; J E Cutler; E E Benson; R F Bargatze; K C Hazen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Characterization of epitopes recognized by Candida factor 1 and 9 antisera by use of Saccharomyces cerevisiae mnn mutants.

Authors:  H Ataoglu; J Zueco; R Sentandreu
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant.

Authors:  W L Chaffin; B Collins; J N Marx; G T Cole; K J Morrow
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues.

Authors:  K C Hazen; D L Brawner; M H Riesselman; M A Jutila; J E Cutler
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis.

Authors:  M Fukayama; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

10.  Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells.

Authors:  Y Miyakawa; T Kuribayashi; K Kagaya; M Suzuki; T Nakase; Y Fukazawa
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.